|
|
|
From
List: Pharmaceutical Companies
|
F/T CT Emply.
|
Annual Revenue
in '000s
|
Senior Officer
|
Title
|
|
|
Rank
BOL CT
|
|
|
Rank
BNH BOL
|
Name
|
|
No. of CT Employees
|
No. of Researchers
|
Capitalization
|
R &D Spending
|
|
|
|
|
|
|
|
|
40
|
WND
|
Arnold Lewis
|
President
|
|
35
|
0
|
WND
|
WND
|
|
|
|
|
|
|
|
|
52
|
WND
|
Peter J. Vitulli
|
President & CEO
|
|
52
|
1
|
WND
|
WND
|
|
|
|
|
|
|
|
|
10
|
$5,000,00$9,999,999
|
John Blanco
|
President
|
|
10
|
2
|
WND
|
WND
|
|
|
|
|
|
|
|
|
1,000
|
$2,702,000,000
|
Paolo Pucci
|
President Pharm Div, Bayer Healthcare
|
|
1,000
|
400
|
|
|
|
|
|
|
|
|
|
|
12
|
WND
|
Anthony Lucas
|
CEO
|
|
12
|
12
|
WND
|
WND
|
|
|
|
|
|
|
|
|
2,000
|
$1,000,000,000
|
J. Martin Carroll
|
President & CEO
|
|
2,000
|
259
|
WND
|
$1,591,000,000
|
|
|
|
|
|
|
|
|
1,200
|
$19,380,000,000
|
Peter Dolan
|
President
|
|
1,200
|
800
|
$49,770,000,000
|
WND
|
|
|
|
|
|
|
|
|
75
|
$2,500,000-$4,999,999
|
Mark G. Lowenstein
|
President
|
|
75
|
2
|
|
|
|
|
|
|
|
|
|
|
10
|
$8,000,000
|
Chris Naughton
|
Managing Director
|
|
10
|
0
|
$367,000,000
|
WND
|
|
|
|
|
|
|
|
|
50
|
WND
|
Hugo Galletta
|
VP
|
|
50
|
10
|
WND
|
WND
|
|
|
|
|
|
|
|
|
30
|
$5,100,000
|
Robert Hennessey
|
CEO
|
|
70
|
WND
|
$219,990,000
|
$17,000,000
|
|
|
|
|
|
|
|
|
6,500
|
$52,520,000,000
|
John LaMattina
|
President PGRD
|
|
6,500
|
4,000
|
$196,140,000,000
|
$7,600,000,000
|
|
|
|
|
|
|
|
|
1,010
|
>$1,000,000,000
|
Michael Friedman
|
president & CEO
|
|
1,010
|
115
|
WND
|
WND
|
|
|
|
|
|
|
|
|
14
|
WND
|
John L. Gells
|
president
|
|
14
|
2
|
N/A
|
N/A
|
|
Footnotes:
|
LEGEND:NR:
= Non -ranked NRO: = Non- ranked, Online Only, NRL
Non-ranked In Print and Online Version
Book of Lists CT rank shown top and Business New Haven
rank bottom, if applicable.
|
|
|